Papers/PMID:24731650
Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.
Clinical nutrition (Edinburgh, Scotland)2015The record
2 findings drawn from this paper, on 1 compound across 2 endpoints, 1 of them null.
What it reported
How to read these marksWhat moved
1 finding
resveratrol — decreases systolic blood pressure (setting unspecified)
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Finding“Subgroup analyses indicated that higher-dose of resveratrol consumption (≥ 150 mg/d) significantly reduces SBP of -11.90 mmHg (95% CI: -20.99, -2.81 mmHg, P = 0.01), whereas lower dose of resveratrol did not show a significant lowering effect on SBP.”
Quoted verbatim from Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Dose
- ≥150 mg/day
- Population
- Meta-analysis of randomized controlled trials of resveratrol supplementation; dose-stratified subgroup receiving ≥150 mg/day resveratrol, not the full 6-trial, 247-subject pooled sample
Effect -11.9 mean difference, 95% CI -20.99 to -2.81
Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.2015PMID:24731650
What did not
1 finding
resveratrol — no detected effect on diastolic blood pressure (setting unspecified)
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull result“The present meta-analysis indicates that resveratrol consumption significantly decreases the SBP level at the higher dose, while resveratrol has no significant effects on DBP levels.”
Quoted verbatim from Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Meta-analysis of 6 randomized controlled trials of resveratrol supplementation (247 subjects total); overall estimate across all doses
Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials.2015PMID:24731650